Table 1. Demographics and Clinical Characteristics of the 72 Patients with ccRCC.
| Parameter | Value | |
|---|---|---|
| Age (y) | 57(51-66) | |
| Tumor maximal diameter (cm) | 6.7(4.1-10.2) | |
| Sex, (%) | ||
| Male | 38(52.7) | |
| Female | 34(47.3) | |
| Tumor location, (%) | ||
| Left | 33(45.8) | |
| Right | 39(54.2) | |
| Vascular cancer embolus, (%) | ||
| Positive | 8(11.1) | |
| Negative | 64(88.9) | |
| Tumor necrosis, (%) | ||
| Positive | 13(18.1) | |
| Negative | 59(81.9) | |
| Sarcomatoid or rhabdoid feature, (%) | ||
| Positive | 6(8.3) | |
| Negative | 66(91.7) | |
| Adverse pathology, (%) * | ||
| Positive | 17(23.6) | |
| Negative | 55(76.4) | |
| pT stage, (%) | ||
| T1 | 26(36.1) | |
| T2 | 13(18.1) | |
| T3 | 22(30.6) | |
| T4 | 11(15.2) | |
| WHO/ISUP grade, (%) | ||
| 1 | 11(15.3) | |
| 2 | 33(45.8) | |
| 3 | 15(20.8) | |
| 4 | 13(18.1) |
*
Adverse pathology: tumor presenting with necrosis or a sarcomatoid or rhabdoid feature. Two of the tumor has both tumor necrosis and sarcomatoid feature.
ccRCC = clear-cell renal cell carcinoma; WHO/ISUP = World Health Organization / International Society of Urological Pathology
Data are median (interquartile range) for age and tumor maximal diameter.